Bleeding due to platelet aggregation inhibitors and other anti-clotting medication is a common problem in clinical practice. This application is before and after interventions give a quick overview of the necessary time intervals. How long should a particular anticoagulant be paused in order to make a spinal anesthesia may? How long must I wait until I after the anticoagulant therapy on again lead? Which anticoagulants, renal function should be considered?
In addition, a simplified PT / INR conversion table is contained.
This application is not meant to be scientific work. You should only present contents of the subject. The information contained in this application is based on the recommendation of the German Society for 3.überarbeitete Anesthesiology and Intensive Care (DGAI) on "neuraxial anesthesia and thromboembolism / undertreatment medication (class S1) (http://www.awmf.org/leitlinien /detail/ll/001-005.html). All information is subject to the accuracy or completeness. The use of this application is at your own risk. decisions in clinical setting should be based on an individual and possibly interdisciplinary risk-benefit analysis. suggestions or criticism I take gladly. Use the Review button!
Disclaimer
This application was developed for training purposes.
The information in this application must be absolutely verified and checked prior to use by the attending physician. The author of this work assumes no responsibility for the accuracy and timeliness of the data presented. Any kind of liability claims from the use of this application will be rejected. If they do not agree, do not install the application.
In addition, a simplified PT / INR conversion table is contained.
This application is not meant to be scientific work. You should only present contents of the subject. The information contained in this application is based on the recommendation of the German Society for 3.überarbeitete Anesthesiology and Intensive Care (DGAI) on "neuraxial anesthesia and thromboembolism / undertreatment medication (class S1) (http://www.awmf.org/leitlinien /detail/ll/001-005.html). All information is subject to the accuracy or completeness. The use of this application is at your own risk. decisions in clinical setting should be based on an individual and possibly interdisciplinary risk-benefit analysis. suggestions or criticism I take gladly. Use the Review button!
Disclaimer
This application was developed for training purposes.
The information in this application must be absolutely verified and checked prior to use by the attending physician. The author of this work assumes no responsibility for the accuracy and timeliness of the data presented. Any kind of liability claims from the use of this application will be rejected. If they do not agree, do not install the application.
